What are the indications of Ixazomib?

Release date: 2026-01-07 17:23:55     Article From: Lucius Laos     Recommended: 106

Ixazomib is a second-generation proteasome inhibitor that has emerged as a pivotal therapeutic option for the treatment of multiple myeloma.

What are the indications of Ixazomib?

Ixazomib is an oral proteasome inhibitor indicated for the treatment of multiple myeloma.[1] As the first oral second-generation proteasome inhibitor approved by the U.S. Food and Drug Administration (FDA), it can be used in combination with dexamethasone and lenalidomide for patients who have received prior therapy, enabling a fully oral treatment regimen. This regimen has been proven to confer progression-free survival benefits. The approval of ixazomib was based on the results of the global phase III TOURMALINE-MM1 study, a double-blind, randomized trial conducted in patients with relapsed/refractory multiple myeloma.

FDA-Approved Indications

Ixazomib is currently approved by the FDA for the treatment of relapsed or refractory multiple myeloma.

Off-Label Use

Ixazomib is sometimes used off-label for the treatment of amyloidosis.

Currently, ixazomib is also under investigation in a phase II clinical trial for patients with Waldenström’s macroglobulinemia. A number of ongoing studies are exploring the use of ixazomib in diseases such as bladder cancer, T-cell lymphoma, and neuroblastoma; however, these applications have not yet been approved.

What adverse effects may Ixazomib cause?

Severe Adverse Effects

Some adverse effects may be severe. Contact your doctor immediately if you experience any of the following symptoms:

Nausea, extreme fatigue, loss of appetite, flu-like symptoms, abnormal bleeding or bruising, yellowing of the skin or eyes, pain in the upper right abdomen, burning, tingling, numbness, pain or weakness in the arms or legs, as well as bloody stools or black, tarry stools.

In addition, ixazomib may cause other adverse effects. During treatment, consult your doctor promptly if you experience any unusual symptoms.

Management of Emergencies/Drug Overdose

If the patient develops coma, seizures, difficulty breathing, or unresponsiveness, call emergency services immediately.

Other Precautions for Ixazomib

Keep all scheduled doctor appointments and laboratory tests. Your doctor will order specific laboratory tests to monitor your body’s response to ixazomib.

Maintain a written list of all prescription drugs, over-the-counter medications, vitamins, minerals, and dietary supplements you are taking. Bring this list with you to every doctor’s visit or hospital admission. It is recommended to carry the list with you at all times for emergency situations.

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Contact US

Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

  • Whatsapp

    Name: Lucius

  • Telegram name: Vira

    No.:0085253923643

Lucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved Lucius Pharmaceuticals Lucius

WhatsApp

Telegram name: Vira

No.:0085253923643